http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-899404-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_571b8abacacea64d3f7089d0983b8b3b |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D251-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D251-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D251-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D251-70 |
filingDate | 1958-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 1962-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | GB-899404-A |
titleOfInvention | Triazine derivatives, the manufacture thereof, and pharmaceutical preparations thereof |
abstract | The invention comprises triazines of the formula <FORM:0899404/IV (b)/1> and their acid addition salts wherein Ar is a 2,6-dimethylphenyl, 2-ethylphenyl or 2-butylphenyl group and R1 and R2 are each an alkyl group having from one to four carbon atoms or R1 and R2 together form a tetramethylene or pentamethylene chain and the preparation thereof by condensing an aniline ArNH2, a ketone R1COR2 and dicyandiamide in the presence of an acid. Anthelmintic compositions comprise compounds of the invention together with a suitable carrier therefor. Examples are given of tablets, chewing wafers, a syrup and an elixir. Specification 720,456 is referred to. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GR-980100275-A |
priorityDate | 1957-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 20.